Core IM | Internal Medicine Podcast cover image

#136 How Did Diabetes Medications Become Obesity Meds? Beyond Journal Club on SURMOUNT-1 Trial

Core IM | Internal Medicine Podcast

00:00

The Role of GLP-1 and GIP Agonists in Diabetes Treatment

This chapter provides an introduction to GLP-1 and GIP agonists used in the treatment of diabetes. It discusses the different brand names and types of agonists, including semaglutide, liraglutide, and terzepitide. The chapter also mentions various trials such as LEDER, SUSTAIN, SOPRAS, and CERPAAS, which evaluated the cardiovascular and weight loss effects of these medications.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app